Publications (34) Publications in which a researcher has participated

1999

  1. A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC)

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 264-270

  2. Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 8, pp. 604-605

  3. CCR5 genotype and HIV-1 infection in perinatally-exposed infants

    Journal of Infection, Vol. 38, Núm. 1, pp. 9-11

  4. CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 5, pp. 389-391

  5. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 4, pp. 256-259

  6. Diabetes mellitus associated with protease inhibitor use

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 9, pp. 675-677

  7. Different outcome in the first two patients with an HIV-1 multinucleoside drug-resistant T69SSS insertion in Spain

    Antiviral Therapy, Vol. 4, Núm. 2, pp. 125-127

  8. Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy

    Journal of Human Virology, Vol. 2, Núm. 6, pp. 344-349

  9. Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy

    JOURNAL OF HUMAN VIROLOGY, Vol. 2, Núm. 6, pp. 344-349

  10. Efficiency of drug resistance genotypic tests in specimens with low HIV viral load

    Antiviral Therapy, Vol. 4, Núm. 2, pp. 123-124

  11. El matrimonio es un contrato (concretamente, un contrato de sociedad)

    Ius canonicum, Vol. 39, Núm. 1, pp. 611-618

  12. Evaluación y desarrollo de las competencias directivas

    Harvard Deusto business review, Núm. 89, pp. 10-27

  13. Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimens

    Antiviral Therapy, Vol. 4, Núm. 3, pp. 179-181

  14. Hepatitis C and HTV infection: Biological, clinical, and therapeutic implications

    Journal of Hepatology, Supplement, Vol. 31, Núm. 1, pp. 119-123

  15. Human T-cell leukemia/lymphoma virus type II infection in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 1, pp. 75-76

  16. Human immunodeficiency virus type 2 infection in Spain

    Intervirology, Vol. 42, Núm. 1, pp. 37-42

  17. Human immunodeficiency viruses type I subtypes circulating in spain

    Journal of Medical Virology, Vol. 59, Núm. 2, pp. 189-193

  18. IV Congreso Internacional sobre tratamieto de la infección por VIH

    Publicación oficial de la Sociedad Española Interdisciplinaria del SIDA, Vol. 10, Núm. 2, pp. 62-65

  19. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users

    European Journal of Epidemiology, Vol. 15, Núm. 1, pp. 1-4

  20. Inhibidores de la proteasa del VIH: Pros y contras

    Medicina Clinica, Vol. 112, Núm. 18, pp. 702-705